-
1
-
-
5444259887
-
Two is better than one? Combination therapy in rheumatoid arthritis
-
Choy E. Two is better than one? Combination therapy in rheumatoid arthritis: Rheumatology 2004;43:1205-7.
-
(2004)
Rheumatology
, vol.43
, pp. 1205-1207
-
-
Choy, E.1
-
2
-
-
0033509841
-
Pharmacokinetics, safety and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis
-
Weinblatt ME, Kremer JM, Coblyn JS et al. Pharmacokinetics, safety and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 1999;42:1322-28.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1322-1328
-
-
Weinblatt, M.E.1
Kremer, J.M.2
Coblyn, J.S.3
-
3
-
-
1542359493
-
The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-α therapy
-
Bingham SJ, Buch MH, Tennant A, Emery P. The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-α therapy. Rheumatology 2004;43:364-8.
-
(2004)
Rheumatology
, vol.43
, pp. 364-368
-
-
Bingham, S.J.1
Buch, M.H.2
Tennant, A.3
Emery, P.4
-
4
-
-
0036166382
-
COBRA combination therapy in patients with early rheumatoid arthritis. Long term structural benefits of a brief intervention
-
Landewe RBM, Boers M, Verhoeven AC et al. COBRA combination therapy in patients with early rheumatoid arthritis. Long term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 347-356
-
-
Landewe, R.B.M.1
Boers, M.2
Verhoeven, A.C.3
-
5
-
-
3142668362
-
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease modifying anti-rheumatic drugs. Five year experience from the FIN-RACo study
-
Korpela M, Laasonen L, Hannonen P et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease modifying anti-rheumatic drugs. Five year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072-81.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2072-2081
-
-
Korpela, M.1
Laasonen, L.2
Hannonen, P.3
-
6
-
-
27744566645
-
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
-
Choy EHS, Smith C, Dore CJ, Scott DL. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology 2005;44:1414-21.
-
(2005)
Rheumatology
, vol.44
, pp. 1414-1421
-
-
Choy, E.H.S.1
Smith, C.2
Dore, C.J.3
Scott, D.L.4
-
7
-
-
0037404908
-
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis
-
Aletaha D, Kapral T, Smolen JS. Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. Ann Rheum Dis 2003;62:482-6.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 482-486
-
-
Aletaha, D.1
Kapral, T.2
Smolen, J.S.3
-
8
-
-
0037027427
-
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate
-
Kremer J, Genovese M, Cannon GW et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. Ann Intern Med 2002;137:726-33.
-
(2002)
Ann Intern Med
, vol.137
, pp. 726-733
-
-
Kremer, J.1
Genovese, M.2
Cannon, G.W.3
-
9
-
-
33744483760
-
Leflunomide and methotrexate combination therapy in daily clinical practice
-
Deendoven A, De Rycke L, Verhelst X, Mielants H, Veys EM, De Keyser F. Leflunomide and methotrexate combination therapy in daily clinical practice. Ann Rheum Dis 2006;65:833-4.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 833-834
-
-
Deendoven, A.1
De Rycke, L.2
Verhelst, X.3
Mielants, H.4
Veys, E.M.5
De Keyser, F.6
-
10
-
-
2642530610
-
Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open label extension of a randomized, double-blind, placebo controlled trial
-
Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open label extension of a randomized, double-blind, placebo controlled trial. J Rheumatol 2004;31:1521-31.
-
(2004)
J Rheumatol
, vol.31
, pp. 1521-1531
-
-
Kremer, J.1
Genovese, M.2
Cannon, G.W.3
Caldwell, J.4
Cush, J.5
Furst, D.E.6
|